List of works by Shashikant Srivastava

A Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the Playground

scientific article

A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky Way.

scientific article

A Human Lung Challenge Model to Evaluate the Safety and Immunogenicity of PPD and Live BCG

scientific article published on 20 December 2019

A Long-term Co-perfused Disseminated Tuberculosis-3D Liver Hollow Fiber Model for Both Drug Efficacy and Hepatotoxicity in Babies

scientific article published on 27 February 2016

Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis

scientific article published on 25 July 2016

Amikacin Pharmacokinetics/Pharmacodynamics in a Novel Hollow-Fiber Mycobacterium abscessus Disease Model

scientific article published on 7 December 2015

Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis

scientific article published on 27 November 2017

Antibiotic Susceptibility of Helicobacter pylori Clinical Isolates: Comparative Evaluation of Disk-Diffusion and E-Test Methods

scientific article published on 12 September 2006

Artificial Intelligence and Amikacin Exposures Predictive of Outcomes in Multidrug-Resistant Tuberculosis Patients.

scientific article published on 25 July 2016

Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis.

scientific article published on 30 August 2017

Comment on: Clinical significance of 2 h plasma concentrations of first-line anti-tuberculosis drugs: a prospective observational study

scholarly article by J. G. Pasipanodya et al published 1 September 2014 in Journal of Antimicrobial Chemotherapy

Comparison of a novel regimen of rifapentine, tedizolid, and minocycline with standard regimens for treatment of the pulmonary Mycobacterium kansasii

scientific article published on 20 July 2020

Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo.

scientific article

Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests

scientific article

Duration of pretomanid/moxifloxacin/pyrazinamide therapy compared with standard therapy based on time-to-extinction mathematics

scientific article published on 01 February 2020

Effect of specimen processing, growth supplement, and different metabolic population on Mycobacterium tuberculosis laboratory diagnosis

scientific article published on 03 April 2020

Efficacy Versus Hepatotoxicity of High-dose Rifampin, Pyrazinamide, and Moxifloxacin to Shorten Tuberculosis Therapy Duration: There Is Still Fight in the Old Warriors Yet!

scientific article published on 01 November 2018

Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol

scientific article published on April 2010

Ethambutol optimal clinical dose and susceptibility breakpoint identification by use of a novel pharmacokinetic-pharmacodynamic model of disseminated intracellular Mycobacterium avium

scientific article published on 15 March 2010

Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection

scientific article published on 25 July 2016

Fatal Lure of Look-Back Studies in Explaining Pharmacological Events Such as Acquired Drug Resistance in Patients With Multidrug-Resistant Tuberculosis

scholarly article by J. Pasipanodya et al published 3 February 2015 in Journal of Infectious Diseases

Gatifloxacin Pharmacokinetics/Pharmacodynamics-based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis

scientific article published on 01 November 2018

In vitro and in vivo modeling of tuberculosis drugs and its impact on optimization of doses and regimens

scientific article published on January 2011

In vitro susceptibility testing and totally drug-resistant tuberculosis

scientific article published in July 2013

Integrating drug concentrations and minimum inhibitory concentrations with Bayesian-dose optimisation for multidrug-resistant tuberculosis

scientific article published in January 2014

Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation

scientific article published on 28 October 2016

Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis

scientific article published on 5 June 2017

Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps

scientific article

Linezolid-based Regimens for Multidrug-resistant Tuberculosis (TB): A Systematic Review to Establish or Revise the Current Recommended Dose for TB Treatment

scientific article published on 01 November 2018

Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy

scientific article

Minimum inhibitory concentration, pharmacokinetics/pharmacodynamics and therapeutic drug monitoring: An integrated approach for multidrug-resistant tuberculosis

scientific article published on July 2015

Minocycline Immunomodulates via Sonic Hedgehog Signaling and Apoptosis and Has Direct Potency Against Drug-Resistant Tuberculosis

scientific article published on 01 February 2019

Moxifloxacin pharmacokinetics/pharmacodynamics and optimal dose and susceptibility breakpoint identification for treatment of disseminated Mycobacterium avium infection

scientific article published on 12 April 2010

Moxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus Disease

scientific article published on 11 April 2016

Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability

scientific article published on 21 October 2011

Multiparameter Responses to Tedizolid Monotherapy and Moxifloxacin Combination Therapy Models of Children With Intracellular Tuberculosis

article

Mycobacterial shuttle vectors designed for high-level protein expression in infected macrophages

scientific article

New susceptibility breakpoints and the regional variability of MIC distribution in Mycobacterium tuberculosis isolates

scientific article published on October 2012

Once-a-week tigecycline for the treatment of drug-resistant TB

scientific article published on 01 June 2019

Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks

scientific article

Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study

scientific article published on 01 October 2019

Pharmacokinetic mismatch does not lead to emergence of isoniazid- or rifampin-resistant Mycobacterium tuberculosis but to better antimicrobial effect: a new paradigm for antituberculosis drug scheduling

scientific article

Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation.

scientific article published on 2 November 2017

Rapid drug tolerance and dramatic sterilizing effect of moxifloxacin monotherapy in a novel hollow-fiber model of intracellular Mycobacterium kansasii disease

scientific article

Reply to “Pharmacokinetic Mismatch of Tuberculosis Drugs”.

scientific article published in March 2012

Scientific and patient care evidence to change susceptibility breakpoints for first-line anti-tuberculosis drugs [Correspondence]

article

Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing

scientific article published on 01 August 2019

Sterilizing Effect of Ertapenem-Clavulanate in a Hollow-Fiber Model of Tuberculosis and Implications on Clinical Dosing

scientific article published on 10 July 2017

Susceptibility Testing of Antibiotics That Degrade Faster than the Doubling Time of Slow-Growing Mycobacteria: Ertapenem Sterilizing Effect versus Mycobacterium tuberculosis

scientific article published on 29 February 2016

Systematic review and meta-analyses of the effect of chemotherapy on pulmonary Mycobacterium abscessus outcomes and disease recurrence

scientific article published on 14 August 2017

The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance

scientific article

Thioridazine as Chemotherapy for Mycobacterium avium Complex Diseases

scientific article published on 23 May 2016

Thioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners

scientific article published on 16 September 2013

Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease

scientific article published on 29 February 2016

Transformation Morphisms and Time-to-Extinction Analysis That Map Therapy Duration From Preclinical Models to Patients With Tuberculosis: Translating From Apples to Oranges

scientific article published on 01 November 2018

UreC PCR based diagnosis of Helicobacter pylori infection and detection of cag A gene in gastric biopsies

article

Urine Colorimetry for Therapeutic Drug Monitoring of Pyrazinamide during Tuberculosis Treatment

scientific article published on 15 December 2017

pH Conditions under Which Pyrazinamide Works in Humans.

scientific article published on 24 August 2017

Paulina is supported by:

About Paulina

Help